REGENERON PHARMACEUTICALS, INC.
All 13F Filings
- Location
- Tarrytown, NY
- Most recent 13F
- Q1 2026
- Holdings value ($000)
- 47,884
- Description
- —
- Website
- —
- Founded
- —
- Chairman
- —
- CEO
- —
- All SEC filings
- View on sec.gov
Sector allocation over time (stocks only)
Stacked by quarter. Hover to see detailed sector breakdown for any quarter.
| Quarter | Date Filed | Holdings | Value ($000) | Form Type | Name |
|---|---|---|---|---|---|
| Q1 2026 | 5/8/2026 | 2 | 47,884 | 13F-HR | REGENERON PHARMACEUTICALS, INC. |
| Q4 2025 | 2/6/2026 | 2 | 33,799 | 13F-HR | REGENERON PHARMACEUTICALS, INC. |
| Q3 2025 | 11/7/2025 | 4 | 700,445 | 13F-HR | REGENERON PHARMACEUTICALS, INC. |
| Q2 2025 | 8/1/2025 | 4 | 1,485,003 | 13F-HR | REGENERON PHARMACEUTICALS, INC. |
Swipe for more columns
Money flow by instrument (QoQ, ex-options)
| Type | Value ($000) | Share % | Inflow | Outflow | Net |
|---|---|---|---|---|---|
| Stocks | 47.88 K | 100.0% | 14.08 K | 0 | 14.08 K |
Swipe for more columns
Fund Snapshot
Q1 2026
Latest filed
5/8/2026
Total value ($000)
47,884
Holdings
2
QoQ value change ($000)
14,085
(41.7%)
Value = total reported 13F value ($000), Holdings = number of positions.
13F Value over time
Holdings count over time
Sector allocation (latest, stocks only)
Methodology:
sector allocation is stocks-only;
instrument flow table is ex-options;
options exposure is shown separately.
Details.